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Abstract
Background: Germline progenitors resist signals that promote differentiation into somatic cells. This occurs through the
transient repression in primordial germ cells of RNA polymerase II, specifically by disrupting Ser2 phosphorylation on its C-
terminal domain.
Methodology/Principal Findings: Here we show that contrary to expectation the Drosophila polar granule component
(pgc) gene functions as a protein rather than a non-coding RNA. Surprisingly, pgc encodes a 71-residue, dimeric, alpha-
helical oligopeptide repressor. In vivo data show that Pgc ablates Ser2 phosphorylation of the RNA polymerase II C-terminal
domain and completely suppresses early zygotic transcription in the soma.
Conclusions/Significance: We thus identify pgc as a novel oligopeptide that readily inhibits gene expression. Germ cell
repression of transcription in Drosophila is thus catalyzed by a small inhibitor protein.
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Introduction
Germline progenitor cells resist signals that promote differen-
tiation into somatic cells during development, thus maintaining
their cell fate. In the fruit fly Drosophila and in many other species,
this occurs through the transient repression of RNA polymerase II
(Pol II) mediated transcription in primordial germ cells [1; 2].
Specifically, this occurs by disrupting the phosphorylation of Ser2
in the C-terminal domain (CTD) of Pol II, a post-translational
modification that promotes transcriptional elongation of the
polymerase. A screen in Drosophila melanogaster identified polar
granule component (pgc) as the gene required for Pol II inhibition and
germ cell establishment [3]. pgc encodes two small ORFs that
diverge within the D. sophophora subgenus and have no obvious
orthologues outside of the genus. These facts, as well as an ORF1
start codon in an unfavourable translation initiation context and
poor codon usage for ORF2, led to the hypothesis that pgc
functions as a transcription-repressing non-coding RNA [1; 3].
In a bioinformatic search for novel, small proteins that may be
involved as cofactors in transcription-related processes, we noted
that pgc ORF1 and ORF2 could encode two 71-residue and 75-
residue oligopeptides (Figure 1A) with significant predicted alpha-
helical structure (Figure 1B). We therefore tested whether these
two ORFs may encode folded proteins and directly assessed
whether Pgc protein may be responsible for the known repressive
roles of the Drosophila pgc gene. Transfection assays clearly reveal
the ability of pgc ORF1 to repress transcription. Further,
microinjection of a folded 71 amino acid ORF1 oligopeptide
readily inhibits zygotic transcription, establishing Pgc protein as a
general transcriptional repressor protein.
Results and Discussion
pgc ORF1 encodes a small, alpha-helical protein
To test whether pgc ORFs encode folded proteins, we recombi-
nantly expressed and purified the two short ORFs encoded by
Drosophila pgc gene in E. coli as (His)6-tagged fusion proteins. While
ORF2 is insoluble, Pgc ORF1 can be refolded and migrates as an
estimated monomer and dimer fraction on a size-exclusion
chromatography column (Figure 1C,D). Furthermore, far-UV CD
assaysrevealalpha-helicalstructureinbothmonomeranddimerPgc
fractions (Figure 1E). Dimeric Pgc ORF1 contains a higher helical
content, as seen by the lower ellipticity at 222 nm wavelength
(dimeric Pgc exhibits a far-UV CD spectrum consistent with ,20%
a-helix and ,25% b-strand content). Thus Pgc may exist in a
dynamic equilibrium between monomer-dimer species. Consistent
with what is often seen for very small proteins, our data suggest that
Pgc ORF1 dimerization may stabilize the protein’s fold.
The Pgc oligopeptide represses Pol II Ser2
phosphorylation
To test whether a short DNA construct encoding Pgc ORF1
(but not the remainder of the pgc sequence) is able to reduce
nuclear Ser2 CTD phosphorylation, we transfected Drosophila Kc
cells with V5-(His)6-tagged pgc ORF1 and ORF2. pgc ORF1
represses Ser2 CTD phosphorylation (Figure 2), while pgc ORF2
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of CTD Ser2 phosphorylation suggests Pgc ORF1 directly or
indirectly functions by repressing normal Pol II function.
In order to directly test whether Pgc protein, rather than its RNA
message, is responsible for the decrease in CTD Ser2 phosphory-
lation in vivo, we micro-injected the anterior pole of stage 3–4
Figure 1. The pgc locus encodes an alpha-helical monomeric and dimeric oligopeptide protein. (A) pgc contains two open reading frames,
encoding potential 71 and 75 residue oligopeptide proteins (Pgc ORF1 and ORF2, respectively). (B) The two candidate oligopeptides are predicted to
contain alpha-helical secondary structure. (C) E. coli expressed and purified Pgc ORF1 is a soluble protein, in contrast to ORF2, which fails to refold in vitro.
(D) Size-exclusion chromatography of PGC ORF1 reveals two chromatographic species, one migrating at 18 kDa, the other at 36 kDa, consistent with
monomer and dimer fractions of (His)6-tagged Pgc ORF1. Absorbance signal at 280 nm (blue) and 260 nm (red). (E) Far-UV circular dichroism
spectroscopy spectrum of purified, recombinant PGC ORF1 reveals that recombinant Pgc ORF1 protein contains intrinsic alpha-helical structure. Peak *1
(red), corresponding to the dimeric Pgc ORF1 complex, contains a higher alpha-helical content than monomeric Pgc1 (peak *2, blue).
doi:10.1371/journal.pone.0002506.g001
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suppresses Ser2 CTD phosphorylation around the injection site
(Figure 3A–H), but does not alter normal levels of CTD
phosphorylation at the posterior pole. Hence, Pgc protein can lower
Ser2 CTD phosphorylation levels in somatic embryonic nuclei.
Pgc protein silences zygotic transcription in the soma
To test whether this inhibitory effect on Pol II phosphorylation
also alters the transcription of early zygotic genes, as would be
predicted for such a dramatic change in CTD Ser2 phosphory-
lation, we probed Pgc-injected embryos for the presence of two
early transcripts [4]. CG3502, whose expression starts after the
11th cleavage division before cellularization, and serpent, whose
expression in the anterior pole starts at cellularization following
the 13th cleavage division. Injection of recombinant Pgc into the
anterior pole fully represses the expression of CG3502 (Figure 4).
Similarly, serpent mRNA is not detected near the injection site,
while posterior pole serpent RNA accumulates normally (Figure 5).
These two assays show that Pgc protein can account for the known
biological roles of the Drosophila pgc gene. In summary, our data
identify a novel, short Drosophila oligopeptide protein that can
efficiently repress zygotic Pol II transcription in the somatic nuclei
of the early embryo. This suggests that pgc encodes a folded
oligopeptide which renders primordial germ cells insensitive
toward somatic differentiation signals by lowering Ser2 CTD
phosphorylation and hence blocking Pol II-mediated transcription.
A recent publication by Hanyu-Nakamura and colleagues
complements our oligopeptide-focused analysis through of a range
of genetic experiments [5]. Further, their studies provide a
molecular hint on the direct or indirect target of Pgc’s repressive
action. Specifically, they identify the Ser2 CTD kinase Cdk9, a
subunit of the positive elongation factor P-TEFb, as the likely
biological target of Pgc function [5]. Pgc fractionates with Cdk9 in
immunoprecipitation assays and affects Cdk9 recruitment to
polytene chromosomes, but does not appear to directly inhibit
P-TEFb CTD kinase activity in vitro [5]. This suggests that Pgc
may sequester Cdk9 activity away from active promoters. It is
currently not known whether Pgc can interact with Cdk9 directly.
Future studies will address the exact mechanism of how Pgc leads
to transcriptional inhibition through repression of Pol II CTD
Ser2 phosphorylation. It will be interesting, for example, to test
whether Pgc alters the ability of the Pol II CTD to interact with
transcriptional elongation and other factors, such as the RNA
processing machinery. High-resolution structural analysis of Pgc
monomers and dimers, for example, should provide important
clues about the protein’s molecular form and function, and
improve the chances of identifying a conserved molecular
structure capable of inhibiting Pol II in species beyond Drosophila.
Our results show that Pgc is an independently-folded oligopep-
tide protein which reduces gene expression by affecting Pol II
CTD phosphorylation. There are other examples of small,
oligopeptide proteins and peptide motifs that regulate gene
expression, notably in the RNAi pathway [6–8]. Our study
identifies a small, 71-residue germ-cell oligopeptide that can
critically regulate gene expression at one of the earliest steps on the
pathway from gene to protein by suppressing the activity of a co-
factor that facilitates transcription. The ability of folded Pgc to
inhibit zygotic transcription upon microinjection suggests it is able
to dynamically associate with (or sequester) cellular, nuclear target
proteins, including the multisubunit transcriptional co-activator P-
TEFb, and lead to a rapid and likely reversible repression of RNA
Pol II Ser2 CTD phosphorylation.
Materials and Methods
Secondary structure predictions
ORF1 and ORF2 of Drosophila pgc were analyzed using a
combination of secondary structure prediction programmes,
including PredictProtein (www.predictprotein.org), IUPred (iupred.en-
zim.hu), GlobPlot 2 (globplot.embl.de) and Agadir [9].
Cloning
pgc ORF1 and ORF2 were PCR-amplified from BDGP clone
RE14873 using Phusion DNA polymerase (Finnzymes). For
Figure 2. Pgc ORF1 abolishes Ser2 phosphorylation on the RNA polymerase II CTD. Transfected Drosophila Kc cells fixed one day after
inducing the expression of V5-(His)6-tagged Pgc ORF1 and ORF2. Pgc-expressing cells are revealed by anti-V5 antibody (middle panels). Upper panels
show that Pgc ORF1 decreases CTD Ser2 phosphorylation (detected using H5 monoclonal anti-phospho-Ser2 antibody). There is no change in CTD
Ser2 phosphorylation upon expression of Pgc ORF2 (lower panels).
doi:10.1371/journal.pone.0002506.g002
Pgc Represses Transcription
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cloned into pETM-11 (a pET-24 derivative) using NcoI and NotI.
For inducible expression in Drosophila cell culture, ORF1 and
ORF2 were cloned into pMT-V5-His (Invitrogen) using EcoRI
and NotI. The resulting Pgc proteins are V5 and His-tagged on
the C-terminus. Constructs were verified by DNA sequencing.
Figure 3. Microinjection of recombinant Pgc protein strongly reduces CTD Ser2 phosphorylation in Drosophila embryonic nuclei.
Pgc was injected (arrows) into the anterior region of stage 3–4 Drosophila embryos. Representative images of embryos fixed 30 minutes after the
injection of Pgc protein (A–H) or buffer only (I–L). DNA detected by Hoechst stain (purple, A, C, D, G, I, K) and CTD phospho-Ser2 (green, B, E, F, H,
J, L). Ser2 phosphorylation strongly decreases at the site of injection (arrow, B). In comparison, somatic cell nuclei in the posterior area of the same
embryo show no changes in Ser2 phosphorylation (H). Ser2 phosphorylation is gradually lost when moving away from the site of injection (E, F,
arrow, left, denotes anterior region). Ser2 phosphorylation does not decrease with control injections (J) when compared to the uninjected area (L).
doi:10.1371/journal.pone.0002506.g003
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Drosophila Kc cells were grown at 25uC in Schneider’s Drosophila
Medium (Invitrogen) supplemented with 10% heat-inactivated
fetal bovine serum (Invitrogen), as well as penicillin and
streptomycin. For the transfection of Kc cells with the pMT-Pgc-
V5His constructs, we used Effectene (Qiagen) according to the
manufacturer’s instructions. We induced Pgc expression with
70 mM CuSO4 (Sigma) 16 hours after transfection and fixed the
cells 24 hours after induction.
Pgc protein expression and purification
His-Pgc protein was expressed in E. coli Rosetta (Novagen) cells
at 37uC for 4 hours and purified from inclusion bodies on a Ni
2+-
NTA column (GE Life Sciences) under denaturing conditions. The
bacterial pellet was resuspended and lysed in a buffer containing
50 mM Tris pH 8.0, 10 mM MgCl2, 1 mM DTT, 1 mM PMSF
and protease inhibitors. The resuspended cells were centrifuged in
a SS34 rotor at 9100 rpm at 4uC for 1 hour. The pellet was
resuspended in a buffer containing 6 M guanidine-HCl, 50 mM
Tris pH 8.0, 250 mM NaCl and extracted for 12–14 hours at
4uC. The suspension was centrifuged in a SS34 rotor at
18000 rpm at 4uC for 2 hours and the supernatant was filtered
through 5 mm and 0.22 mm filters. The extract was diluted 1:10 in
equilibration buffer (6 M Urea, 50 mM Tris pH 8.0, 250 mM
NaCl, 15 mM Imidazole, 5 mM b-mercaptoethanol) and loaded
onto a HisTrap HP (GE Healthcare) column. After loading, the
resin was washed with 8 column volumes of equilibration buffer.
The bound protein was eluted with equilibration buffer containing
500 mM Imidazole. The eluate was diluted to 1 mg/ml in
equilibration buffer and dialyzed in 1 L of a buffer containing 5 M
Urea, 5% glycerol, 250 mM NaCl, 50 mM Na2HPO4/NaH2PO4
pH 8.0, 5 mM DTT and 25 mM Tris pH 8.0 at 4uC using
Spectra/Por (Spectrum) dialysis membranes with a cut off of
3.5 kDa. After 1 hour of dialysis, the protein was dialyzed
overnight into PBS containing 5% glycerol. Recombinant Pgc is
.99% nucleic-acid free, as determined by absorbance measure-
ments at 260/280 nm wavelength. Pgc protein was stored at 4uC.
The biological activity of Pgc was measured by microinjecting
embryos with refolded Pgc and determining the inhibition of Ser2
phosphorylation in the CTD of Pol II.
Drosophila embryo injections
For the injection of Drosophila embryos with bacterially purified
Pgc (200 mM) in PBS containing 5% glycerol, 0–1 hour old
embryos were collected from white
1118 flies kept on apple juice agar
at 19uC and 65–70% humidity. Each embryo was injected with
100–200 picolitre of Pgc. For control experiments, we injected the
same volume of dialysis buffer (PBS). The eggs were aged at 19uC
and 65–70% humidity until fixation and prepared for injection
using standard protocols. Before injection, they were dechorio-
Figure 4. The 71-residue Pgc oligopeptide readily suppresses an early zygotic transcript in Drosophila somatic nuclei. (A) Fluorescent
in situ hybridization with an antisense RNA probe for CG3502, a transcript in the anterior region of the embryo whose expression starts during the
11
th cleavage cycle. CG3502 mRNA accumulates in the nucleus before the 13
th cleavage division (A, B) and redistributes to the cytoplasm during
cellularization (C). (D) No detectable CG3502 mRNA one hour after purified Pgc is injected into the anterior region of the embryo. The three
representative embryos are developmentally beyond the 11
th cleavage division and should thus be expressing CG3502.
doi:10.1371/journal.pone.0002506.g004
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(Atochem). For injections, we used Femtotips I microinjection
needles (Eppendorf) on an Eppendorf microinjector. Injected
embryos were aged further before fixation. To analyze the effect of
refolded Pgc on CTD Ser 2 phosphorylation, we injected 2–
3 hour old embryos and aged them 30 minutes after injection until
cellularization was observed in the majority of the injected
embryos. For RNA in-situ hybridizations, embryos were aged
1 hour following Pgc injection. Pre-cellularization embryos were
staged by counting Hoechst-stained nuclei, while later stages were
determined by measuring the average length of elongating nuclei
(from 3–4 to 10–15 mm).
Immunostainings
We used standard protocols to perform immunostainings [10].
Kc cells were fixed in 4% formaldehyde for 10 minutes, washed in
PBS-Tween 20 (0.05%) and blocked in 5% milk in PBS-Tween 20
for 1 hour. Drosophila embryos were fixed by rotating them in 1
part heptane (Sigma):1 part 4% formaldehyde for 10 minutes and
devitellinized in 1 part heptane:1 part methanol (Sigma) with
vigorous shaking for 1 minute. Devitellinized embryos were
washed in methanol, rehydrated in PBS-Tween 20 (0.5%) and
blocked in 5% milk in PBS-Tween 20 for 1 hour. We incubated
the fixed cells and embryos with the primary antibodies at 4uC
overnight and the secondary antibodies at room temperature for
3 hours. We used mouse monoclonal anti-phospho-Serine2 CTD
(H5) antibody (Covance; at 1:800 dilution) and rabbit polyclonal
anti-V5 antibody (Abcam at 1:1000 dilution). Hoechst stain
labelled DNA. The samples were mounted using VectaShield
mounting medium.
RNA in situ hybridizations of somatic transcripts
Fluorescent in situ hybridizations was performed as described by
the Krause laboratory (http://www.utoronto.ca/krause/). DIG-
labeled RNA probes were made through PCR amplification of
BDGP DGC clones LD34564 and LD16058 using T7, T3 or SP6
primers (Invitrogen) and subsequent in vitro transcription using T7,
T3 or SP6 RNA polymerases (Fermentas) and DIG RNA-labelling
mix (Roche). We used biotin-conjugated mouse monoclonal anti-
DIG antibody (Jackson ImmunoResearch) and Alexa Fluor 488
TSA Kit T-20932 (Invitrogen) for signal amplification. All imaging
with a Leica TCS SP2 AOBS (Leica Microsystems) confocal
microscope.
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Figure 5. Suppression of a later zygotic transcript in Drosophila somatic nuclei by the Pgc oligopeptide. Fluorescent in situ hybridization
with an RNA probe detecting serpent mRNA. There is no detectable maternal supply of serpent mRNA (A). serpent mRNA is first detectable at the
posterior end during cleavage cycle 11 (B). The amount of serpent mRNA increases further until cellularization in the posterior somatic nuclei without
detectable expression in the anterior nuclei (C). Upon cellularization, serpent mRNA is detected in two anterior areas: in cells in the anterior pole and
in an antero-ventral cell group (D). As cellularization progresses, the cells become columnar, and serpent mRNA signals further increase in the anterior
cell groups (E, F). (G) Representative images of cellularizing embryos that have been injected with purified Pgc in the anterior region (arrows). Pgc
injection suppresses serpent mRNA accumulation in the anterior region (compare with D–F).
doi:10.1371/journal.pone.0002506.g005
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